z-logo
open-access-imgOpen Access
Treatment of Hyaluronic Acid Filler–Induced Impending Necrosis With Hyaluronidase: Consensus Recommendations
Author(s) -
Joel L. Cohen,
Brian S. Biesman,
Steven Dayan,
Claudio DeLorenzi,
Val Lambros,
Mark S. Nestor,
Neil S. Sadick,
Jonathan M. Sykes
Publication year - 2015
Publication title -
aesthetic surgery journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.528
H-Index - 58
eISSN - 1527-330X
pISSN - 1090-820X
DOI - 10.1093/asj/sjv018
Subject(s) - medicine , hyaluronidase , massage , lidocaine , aspirin , soft tissue , surgery , saline , intensive care medicine , anesthesia , alternative medicine , pathology , biochemistry , chemistry , enzyme
Injection-induced necrosis is a rare but dreaded consequence of soft tissue augmentation with filler agents. It usually occurs as a result of injection of filler directly into an artery, but can also result from compression or injury. We provide recommendations on the use of hyaluronidase when vascular compromise is suspected. Consensus recommendations were developed by thorough discussion and debate amongst the authors at a roundtable meeting on Wednesday June 18, 2014 in Las Vegas, NV as well as significant ongoing written and verbal communications amongst the authors in the months prior to journal submission. All authors are experienced tertiary care providers. A prompt diagnosis and immediate treatment with high doses of hyaluronidase (at least 200 U) are critically important. It is not felt necessary to do a skin test in cases of impending necrosis. Some experts recommend dilution with saline to increase dispersion or lidocaine to aid vasodilation. Additional hyaluronidase should be injected if improvement is not seen within 60 minutes. A warm compress also aids vasodilation, and massage has been shown to help. Some experts advocate the use of nitroglycerin paste, although this area is controversial. Introducing an oral aspirin regimen should help prevent further clot formation due to vascular compromise. In our experience, patients who are diagnosed promptly and treated within 24 hours will usually have the best outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom